Advances in saponin-based adjuvants

HX Sun, Y Xie, YP Ye - Vaccine, 2009 - Elsevier
Saponins are natural glycosides of steroid or triterpene which exhibited many different
biological and pharmacological activities. Notably, saponins can also activate the …

Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy

R Velez, M Gállego - Tropical Medicine & International Health, 2020 - Wiley Online Library
Canine leishmaniosis is an important vector‐borne zoonosis caused mainly by Leishmania
infantum. Diagnosis and treatment of affected individuals can be particularly complex …

Canine leishmaniosis–new concepts and insights on an expanding zoonosis: part two

G Miro, L Cardoso, MG Pennisi, G Oliva, G Baneth - Trends in parasitology, 2008 - cell.com
Canine leishmaniosis is a widely spread zoonosis that is potentially fatal to humans and
dogs. Infection with Leishmania infantum is considerably more prevalent than clinical …

One Health: the global challenge of epidemic and endemic leishmaniasis

CB Palatnik-de-Sousa, MJ Day - Parasites & vectors, 2011 - Springer
Abstract'One Health'proposes the unification of medical and veterinary sciences with the
establishment of collaborative ventures in clinical care, surveillance and control of cross …

Vaccines for leishmaniasis in the fore coming 25 years

CB Palatnik-de-Sousa - Vaccine, 2008 - Elsevier
Human vaccination against leishmaniasis using live Leishmania was used in Middle East
and Russia (1941–1980). First-generation vaccines, composed by killed parasites induce …

Vaccine candidates for leishmaniasis: a review

R Nagill, S Kaur - International immunopharmacology, 2011 - Elsevier
Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …

Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs

C Maia, L Campino - Frontiers in cellular and infection microbiology, 2018 - frontiersin.org
Canine leishmaniosis (CanL) is a vector-borne disease caused by the protozoan
Leishmania (Leishmania) infantum species [syn. L.(L.) infantum chagasi species in the …

Leishmaniasis and various immunotherapeutic approaches

Y Taslimi, F Zahedifard, S Rafati - Parasitology, 2018 - cambridge.org
Leishmaniasis is a vector-borne infectious disease caused by multiple Leishmania (L.)
species with diverse clinical manifestations. There is currently no vaccine against any form …

Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease

BM Roatt, RDO Aguiar-Soares, W Coura-Vital… - Frontiers in …, 2014 - frontiersin.org
Leishmaniasis has several clinical forms: self-healing or chronic cutaneous leishmaniasis or
post-kala-azar dermal leishmaniasis; mucosal leishmaniasis; visceral leishmaniasis (VL) …

Vaccines for canine leishmaniasis

CB Palatnik-de-Sousa - Frontiers in immunology, 2012 - frontiersin.org
Leishmaniasis is the third most important vector-borne disease worldwide. Visceral
leishmaniasis (VL) is a severe and frequently lethal protozoan disease of increasing …